Inflammation and Oxidant Stress in Cystic Fibrosis Related Diabetes
Study Type:
Observational
Intervention Category:
Not Applicable
Study Sponsor:
Stecenko, Arlene
Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.
Study Phase:
Other
Recruitment Status:
Trial Completed
Study Drug(s):
Not Applicable
Number of Participants Being Recruited:
40
Single / Multi-Center:
Single Center
STUDY BACKGROUND INFORMATION:
People with CF and Cystic Fibrosis Related Diabetes (CFRD) have high levels of glucose in the airway compared to people without CF or CFRD or those with type 1 or type 2 diabetes. This high level of glucose in the airway could cause an inflammatory response and oxidant stress in the lung and subsequently systemic stress. This can lead to worsening glucose impairment and worsening hyperglycemia. This study will seek to find out what are the inflammatory molecules with high blood sugar and which molecule are the most sensitive to detect.
ELIGIBILITY
Age:
>= 18 Years
FEV1:
Not Applicable
P. aeruginosa status:
Not applicable
B. cepacia status:
Not applicable
Other Primary Eligibility Requirements:
Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.
The sites listed below are currently recruiting subjects. Please note that this list generally lists either the pediatric or adult program but not both even though both programs may be recruiting subjects. Also, this list does not include sites that may be participating in the study but are not yet open for recruitment. If you are interested in this study please contact your center for more information.
GA
Emory University (Adult), Atlanta, GA, 30322
Contact Information:
Hunter, Eric Phone: (404) 727-9960 Email: eahunte@emory.edu
